Copy Link Print Information

Baricitinib

(Synonyms: LY3009104; INCB028050)
78 Cited Publications
Avis client

Based on 78 publication(s) in Google Scholar

Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.93%
  • CAS No.: 1187594-09-7
  • Formule: C16H17N7O2S
  • Masse moléculaire:371.42
  • Stockage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Baricitinib Chemical Structure
  • Experimental Validation Results for Baricitinib
  • Experimental Validation Results for Baricitinib
  • Experimental Validation Results for Baricitinib
  • Baricitinib Chemical Structure
    Baricitinib Chemical Structure
  • Experimental Validation Results for Baricitinib
  • Experimental Validation Results for Baricitinib
  • Experimental Validation Results for Baricitinib
CAS No.: 1187594-09-7
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Baricitinib:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Baricitinib

More
Customer Validation & Images
WB
  • WB
  • WB
  • WB

Voir tous les produits spécifiques à Isoform JAK

More
Keywords
100 mg

Obtenir un devis En stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Baricitinib Chemical Structure
    Baricitinib Chemical Structure
    1/16
  • 1/16

    Baricitinib purchased from MedChemExpress. Usage Cited in: RSC Adv. 2018 Jun 13;8(38):21534-21540. [Abstract]

    Customer Validation
     M14 and A2058 cells are treated with IFN-γ (10 ng/mL) after Lac (100 μg/mL) or baricitinib (0.5 μM) for the indicated times. Whole cell lysates are subjected to western blotting.

  • 1/16

    Baricitinib purchased from MedChemExpress. Usage Cited in: University of Toyama. 2018, Nov.

    Customer Validation
     Western analysis of pJAK2, JAK2, pSTAT1, STAT1 and IRF1 protein in M14 and A2058 cells treated with IFN-g (10 ng/mL) after Lac (100 μg/mL) or baricitinib (0.5 μM) for the indicated times.

  • 1/16

    Baricitinib purchased from MedChemExpress. Usage Cited in: PLoS One. 2017 Jul 14;12(7):e0181126. [Abstract]

    Customer Validation
     An activator of Stat3, colivelin (0.1 or 1 µM), rescued Baricitinib-induced RANKL down-regulation in osteoblast cultures.

  • Baricitinib